Back to search

Article

Combination Treatment with NCX 4040 and Napabucasin Triggers Enhanced Oxidative Stress, STAT3 Inhibition and Plausible Immunogenic Activation in Metastatic Prostate Cancer Cells

2025-09-15

Abstract excerpt

Prostate cancer (PCa) remains a significant health concern, ranking as the second most common cancer after lung cancer, despite recent advances in diagnostics and therapeutics. Due to its heterogeneous nature, diverse etiology, and the limited efficacy of current treatments, developing a therapeutic approach that can address the multifaceted aspects of the disease is imperative. Combinatorial therapy has emerged a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d0306907-e1fc-5b58-b302-66475cdc43ba
DOI
10.1101/2025.09.09.675191
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Combination Treatment with NCX 4040 and Napabucasin Triggers Enhanced Oxidative Stress, STAT3 Inhibition and Plausible Immunogenic Activation in Metastatic Prostate Cancer CellsDOI 10.1101/2025.09.09.675191
Select a neighboring publication to make it the new centre.